Transformed Medical Weight Loss Solutions operates as a telehealth-focused weight loss clinic serving patients throughout Brooklyn, NY, and surrounding areas under the clinical direction of Ongo Weight Loss. The practice holds LegitScript certification, indicating compliance with healthcare standards for telemedicine prescribing and patient safety protocols. The clinic specializes exclusively in medical weight management using GLP-1 receptor agonist medications, with particular emphasis on patients struggling with chronic weight management, metabolic dysfunction, and type 2 diabetes who have not achieved sustainable results through diet and exercise alone.
The treatment protocol centers on three FDA-approved GLP-1 medications: semaglutide, liraglutide, and tirzepatide. Semaglutide is offered as a once-weekly subcutaneous injection that mimics the glucagon-like peptide-1 hormone to reduce appetite and slow gastric emptying. Liraglutide provides a daily injection option for patients who prefer more frequent dosing or have specific metabolic profiles that respond better to this formulation. Tirzepatide represents a dual GIP/GLP-1 receptor agonist, offering enhanced glycemic control and weight reduction for patients with more complex metabolic presentations or those who require additional therapeutic potency beyond single-pathway GLP-1 agonists. Medication selection and dosing are individualized based on patient history, current metabolic markers, weight loss goals, and tolerance to initial titration schedules.
Clinical oversight is provided by nurse practitioners affiliated with Ongo Weight Loss, who conduct comprehensive telehealth consultations to assess patient candidacy, review contraindications, and establish baseline metabolic parameters before initiating therapy. The intake process includes evaluation of BMI, previous weight loss attempts, comorbid conditions such as hypertension or dyslipidemia, and medication history to identify potential drug interactions. Patients receive detailed injection training during their initial consultation, with follow-up appointments scheduled to monitor dose tolerance, adjust titration schedules, and address side effects such as nausea or gastrointestinal discomfort that commonly occur during the early treatment phases. The nurse practitioners maintain ongoing communication with patients between scheduled visits to answer questions about injection technique, storage requirements, and symptom management.
The patient experience is structured around virtual consultations conducted via HIPAA-compliant video platform, eliminating the need for in-person office visits while maintaining clinical rigor and provider accessibility. After the initial assessment, patients receive their prescribed medication through partnered pharmacies with direct-to-home delivery throughout the Brooklyn area. Follow-up consultations typically occur every four weeks during the dose escalation phase, then transition to maintenance intervals once therapeutic dosing is achieved and weight loss plateaus. The clinic provides patients with specific guidance on managing common GLP-1 side effects, recognizing signs that require dose adjustment, and integrating dietary modifications that complement the appetite-suppressing effects of these medications. Patients are educated on realistic weight loss timelines, with most individuals experiencing gradual reduction over several months rather than rapid drops that prove difficult to sustain.
Transformed Medical Weight Loss Solutions differentiates itself through its exclusive focus on pharmacological weight management rather than attempting to combine multiple treatment modalities that dilute clinical expertise. The telehealth delivery model serves Brooklyn residents who face time constraints, mobility limitations, or prefer the privacy of remote consultations for weight management discussions. The LegitScript certification provides verification that prescribing practices meet national standards for controlled substance handling and patient screening, addressing concerns some patients have about the legitimacy of online weight loss services. For individuals in Brooklyn, NY, seeking physician-supervised GLP-1 therapy without the overhead of traditional medical weight loss centers, this clinic offers a streamlined, medication-focused approach to chronic weight management and metabolic health optimization.
Ongo Weight Loss
Dr. Johnathan Miller, MD
Licensed Physician
Dr. Miller is a licensed physician providing physician-guided weight loss and metabolic health care aligned with recognized clinical guidelines. He received his medical degree from Columbia University and completed postgraduate training at Washington University in St. Louis. Dr. Miller conducts personalized medical evaluations and may prescribe treatment when appropriate.
Dr. Niles, MD
Licensed Physician
Dr. Niles is a licensed physician with over 30 years of clinical experience who provides physician-guided weight loss consultations centered on personalized care. She evaluates each patient's medical history and individual goals to determine appropriate treatment options when indicated.
Dr. Krasne, MD
Board-Certified Physician
Dr. Krasne is a board-certified physician who conducts personalized weight loss evaluations and provides physician-guided care. He completed his medical training at the University of Florida and the University of Miami Miller School of Medicine, with residency completed in 2017. When clinically appropriate, he may prescribe GLP-1 medications based on individual health needs.
Dr. Bugailiskis, MD
Licensed Physician
Dr. Bugailiskis is a licensed physician who provides personalized, physician-guided weight loss care. She earned her medical degree from the University of Illinois at Chicago and works with patients to evaluate their health history, goals, and clinical needs when determining appropriate treatment options.
Topics Mentioned in Reviews
Wegovy (Semaglutide)
An FDA-approved GLP-1 medication for chronic weight management. Intended for adults with obesity (BMI 30+), or overweight (BMI 27–29.9) with related health conditions. Once-weekly injection designed to fit into your routine. Clinically studied to support meaningful, sustainable weight loss.
Zepbound (Tirzepatide)
Zepbound contains tirzepatide, a dual-action GLP-1/GIP medication FDA-approved for chronic weight management in adults with obesity (BMI 30+), or overweight (BMI 27–29.9) with related health conditions. Once-weekly injection with dual-mechanism of action.
Ozempic (Semaglutide)
FDA-approved for adults with type 2 diabetes, used alongside a healthy diet and regular physical activity to help improve blood sugar control. Convenient once-a-week injection clinically studied to help lower A1C levels.
Mounjaro (Tirzepatide)
FDA-approved for adults with type 2 diabetes, used alongside a healthy diet and regular physical activity to help improve blood sugar control. Convenient once-weekly injection clinically studied to help lower A1C levels.
Rybelsus (Semaglutide)
Approved by the FDA for use in adults with type 2 diabetes, taken alongside a healthy diet and regular physical activity to help improve blood sugar control. Taken once daily as an oral tablet.
Liraglutide (Victoza/Saxenda)
Liraglutide is an FDA-approved GLP-1 medication used for type 2 diabetes (Victoza) and chronic weight management (Saxenda) in eligible adults, alongside diet and lifestyle changes. Once-daily injection.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.
